Bioelectronics Corp (BIEL)

[srinsocal]

Thanks longtrailer & Hawk, initially I had only read the isolated paragraph concerning the Voltaren ActiPatch.

Looking at the whole article gives a different perspective. This article was written by an established analyst, "By Dr. Elena Voss, Senior Pharma Market Analyst: Voltaren's evolution from Novartis/GSK joint venture legacy to Haleon's core growth driver underscores its enduring appeal in high-margin OTC markets like Switzerland's pain relief sector."

Dr. Voss does a deep dive into Haleon's Voltaren product. It sure sounds like she had a source inside of Haleon for her article.

New product R&D does not always make it onto store shelves, but I feel confident that Haleon is exploring a Voltaren ActiPatch Hybrid.